Le virus de la maladie de Marek (MDV) est un virus oncogène responsable des lymphomes T chez les poulets. L´infection par ce virus est divisée en une phase lytique dépendante de l´expression du gène très précoce ICP4 et une phase latente, caractérisée par l´expression de l’ARN long non codant LAT localisé en antisens. Nous avons montré que l’expression différentielle des miARN du cluster mdv1-miR-M8-M10 était directement corrélée à l’épissage alternatif de l’intron 1 du LAT et plus particulièrement à la biogenèse par le splicéosome du premier mirtron viral. La présence du mirtron mdv1-miR-M6 au milieu du cluster est associée à une cinétique d’expression des miARN. En parallèle, nous avons identifié deux promoteurs alternatifs de type Sp1, quatre signaux poly-A et trois exons associés à la régulation de la transcription du transcrit ICP4. Nous avons prédits cinq isoformes potentielles pour la protéine ICP4 et avons pu observer par immunodétection que la protéine était exprimée principalement dans le cytoplasme des cellules infectées en phase lytique ou de réactivation. / The Marek disease virus (MDV) is an oncogenic herpesvirus responsible of T-cell lymphoma in chicken. MDV infections are divided into a lytic phase, depending on the expression of immediate early gene like ICP4, and a latent phase characterized by the expression of the long non-coding RNA LAT localized in antisense. In this study, we have shown the differential expression of the cluster of miRNA mdv1-miR-M8-M10 was directly correlated with the alternative splicing of LAT’s intron 1 and more specifically with the first viral mirtron biogenesis by the spliceosome. The location of the mirtron mdv1-miR-M6 inside of the cluster is associated with a two-step biogenesis of the miARN of the cluster. On the other hand, we have identified a dual promoter that responded to Sp1, four poly-A signals and three exons that are responsible of transcriptional regulation of ICP4 transcript. We also have predicted five potential isoproteines for ICP4 and were able to observe by immunodetection that ICP4 was mainly expressed in the cytoplasm of infected cells during the lytic phase or the reactivation one.

Le muscle squelettique (MS) est un tissu métabolique important. L'objectif de ma thèse était de caractériser le rôle des corégulateurs de la transcription, PGC-1β (transcriptional coactivator peroxisome proliferator-activated receptor-gammacoactivator 1beta) et TIF2 (Transcriptional Intermediary Factor 2) dans ce tissu. Mon travail a démontré que PGC-1β limite le stress oxydatif est crucial dans le maintien de la structure et de la fonction mitochondriale, via le contrôle de l’expression de gènes impliqués dans les voies de signalisation liées à l’énergie, à la dynamique mitochondriale et à la machinerie d’import mais n'est pas indispensable pour le contenu mitochondrial. Mon travail aussi démontré que TIF2 de la MS a un impact négatif sur la durée de vie des mammifères. De plus, la déplétion de TIF2 conduit à une protection partielle du MS contre les dommages oxydatifs induits par le stress. Ainsi notre travail représente une avancée dans l’établissement futur de traitements contre les troubles liés au stress oxydatif et au vieillissement. / Skeletal muscle (SM) accounting for ~ 40% of total body mass is an important metabolic tissue. The aim of my thesis was to characterize the role of transcriptional coregulators, peroxisome proliferator-activated receptor-gamma coactivator-1β (PGC-1β) and transcriptional intermediary factor 2 (TIF2) in this tissue. My work demonstrated that PGC-1β is crucial to maintain SM mitochondrial structure and function, by controlling expression of genes involved in energy pathways, mitochondrial dynamics and import machinery, but is dispensable for mitochondrial content and fiber type maintenance. Furthermore, it limits oxidative stress. The second part of my work demonstrated that myofiber TIF2 has negative impact onmammalian life span. Moreover, TIF2 ablation leads to partial protection of SM from oxidative stress-induced damage. In conclusion, our work provides a better understanding of SM homeostasis regulation and insights in treatments for disordersrelated to oxidative stress and aging.

Le récepteur de la vitamine D (VDR) est un facteur de transcription activé par la forme active de la vitamine D3. VDR est une cible thérapeutique potentielle pour de multiples pathologies telles que les maladies auto-immunes et neurodégénératives et certains cancers. VDR module l’expression de gènes par le recrutement sélectif de corégulateurs. Les données structurales disponibles à ce jour pour des complexes de récepteur nucléaire-corégulateurs sont très limitées. Cette étude se focalise sur l’architecture du complexe formé par VDR et un grand fragment du coactivateur MED1, une sous-unité du complexe Médiateur qui fait le lien entre les récepteurs nucléaires et la machinerie basale de transcription. Les résultats obtenus nous sont permis de caractériser l'interaction du récepteur avec le coactivateur et de révéler l'architecture globale du complexe. Ce travail fournit une base solide pour la détermination structurale d’autres complexes impliqués dans le contrôle de la transcription. / The vitamin D nuclear receptor (VDR) is a transcription factor activated by the biologically active form of vitamin D3. VDR is a potential candidate to treat neurodegenerative and autoimmune disorders, and cancer. VDR modulates the expression of vitamin D3-regulated genes by selective recruitment of coregulators of transcription which are, in turn, attractive targets in epigenetic-oriented drug discovery. Available structural data for receptor-coregulator complexes are limited; investigation of such complexes is highly important. The present work focuses on the architecture of the complex between VDR and a large part of the coactivator MED1, a subunit of the Mediator complex linking nuclear receptors to the basal transcription machinery. Obtained results revealed important details of the interaction, as well as the overall organization of the complex. This work provides a solid background for the structural investigation of similar complexes involved in the transcriptional control.

Les facteurs de transcription de la famille p53 dans l’atrophie musculaire - Implications dans la Sclérose Latérale Amyotrophique et la cachéxie. L’atrophie musculaire est un symptôme dangereux retrouvé dans plusieurs maladies. Dans la sclérose latérale amyotrophique (SLA), une maladie neuromusculaire rare, ainsi que dans le cancer (phénomène de cachexie), l’atrophie musculaire cause le décès des patients. Les facteurs de transcription de la famille p53 sont impliqués dans de nombreux processus cellulaires, faisant face à des situations de « stress » pour les cellules. Notamment, ils peuvent induire la mort cellulaire ou promouvoir la différentiation.Nous avons constaté, à partir de modèles cellulaire et animaux de SLA et cachéxie cancéreuse, que des membres de la famille p53 sont activés dans les muscles atrophiques. Cette activation entraine l’expression de gènes cibles impliqués dans la mort cellulaire. De manière intéressante, TAp73, mais surtout TAp63, sont capables d’activer la transcription d’un effecteur de l’atrophie musculaire appelé MuRF1, démontrant que la famille p53 peut participer activement à l’atrophie en induisant la dégradation des fibres musculaires.De plus, nous avons utilisé nos modèles animaux pour identifier une nouvelle approche contre l’atrophie musculaire. Ainsi, nous avons identifié un dérivé de tocophérol avec des propriétés thérapeutiques intéressantes. / The p53 family of transcription factors in muscular atrophy - Involvements in Amyotrophic Lateral Sclerosis and cachexia Muscular atrophy is a dangerous condition found in several diseases. In amyotrophic lateral sclerosis (ALS), a rare neuromuscular disease, as well as in cancer (phenomenon of cachexia), muscular atrophy can be fatal to patients.The transcription factors from the p53 family are involved in several cellular processes, facing cellular “stress” situations. Most notably, they can induce dell death or promote differentiation.We found, using cellular and mouse models of ALS and cachexia, that members of the p53 family are induced during muscular atrophy. This induction leads to the expression of canonnic target genes involved in cell death. Interestingly, TAp73, but especially TAp63, are able to activate the transcription of an effector or muscular atrophy called MuRF1. This proves that the p53 family cand participate in muscular atrophy by promoting the breakdown of muscle fibres.In addition, we used our mouse models to identifiy a new approach agains muscular atrophy.Indeed, we identified a derivative of tocopherol with interesting therapeutical proprieties.

Malgré l'amélioration des traitements, environ 20% des patients atteints de leucémie aigue lymphoblastiques (LAL) rechutent dans la moelle osseuse ou dans des sites extra-médullaires tels que les ovaires et les testicules, ce qui est particulièrement fréquent dans les rechutes tardives de LAL-B présentant un remaniement ETV6/RUNX1. Les travaux réalisés par Virginie Gandemer en 2007, ont montré que l'expression de CD9 permettait de distinguer les leucémies ETV6/RUNX1 des autres types de leucémie. Le gène CD9 code pour une protéine de la famille des tétraspanines dont l'expression a été corrélée avec le risque métastatique et la survie des patients. Par ailleurs il a été démontré que la protéine CD9 était impliquée dans le homing et la prise de greffe des cellules souches hématopoïétiques et leucémiques. Nous avons donc émis l'hypothèse qu'à travers ses propriétés fonctionnelles sur la migration et le homing, CD9 pourrait être un acteur clé des rechutes de LAL-B. Le but de ce travail de thèse était donc premièrement de déterminer le mode de régulation de CD9 dans les LAL-B ETV6/RUNX1 et deuxièmement de déterminer les effets de l'expression de CD9 sur la motilité et la prise de greffe des LAL-B. Les analyses préalablement réalisées au laboratoire avaient suggéré que CD9 pouvait être régulé par des miARNs. Nous avons identifié un cluster de 3 miARNs potentiellement impliqués dans la régulation de CD9 dans les LAL-B ETV6/RUNX1. Ces résultats doivent cependant être complétés par d'autres analyses fonctionnellles afin d'être confirmés. Nous avons étudié le rôle de la protéine CD9 dans la dissémination des cellules de LAL-B. Nous avons démontré que CD9 était un régulateur potentiel de l'adhésion et un nouveau facteur impliqué dans la migration et le homing dépendants de CXCR4 en favorisant l'activation de RAC1 et les réarrangements de l'actine en réponse au CXCL12. Enfin, nous avons décrit pour la première fois l'influence de CD9 sur la migration et le homing dans les testicules via RAC1. Nos résultats montrent donc que CD9 favorise la dissémination des cellules de LAL-B dans les testicules et suggèrent que cette protéine pourrait constituer un acteur majeur des rechutes tardives de LAL-B dont les mécanismes d'apparitions sont peu connus. / Despite improvements in survival rates, approximately 20% of children suffering from acute lymphoblastic leukemia (B-ALL) present relapses from bone marrow or from B-extramedullary sites, such as the testes or ovaries, particularly in cases of late relapse of ETV6/RUNX1-ALL. Virgine Gandemer showed in 2007, that the expression of CD9, a protein from the tetraspanin superfamily, can be used to distinguish ETV6/RUNX1 lymphoblastic leukemia from other types of ALL. CD9 expression has been correlated with the risk of metastasis and is associated with a poor clinical outcome in various types of cancer. Moreover CD9 has been implicated in hematopoietic and leukemic stem cell homing. We hypothesized, that CD9 protein, through its functional properties on migration and homing, could be a key actor of B-ALL relapses. The purpose of our study was then to investigate, first the transcriptional regulation of CD9 in ETV6/RUNX1 B-ALL and secondly, the effect of CD9 expression on motility and engrafment of B lymphoblasts. The analysis of CD9 transcriptional regulation previously made in the team, suggested that it could be regulated by miRNAs. We identified a cluster of 3 miRNAs potentially implicated in the regulation of CD9 expression in ETV6/RUNX1 B-ALL. This result has to be confirmd by more functional analysis. We investigated the role of CD9 in the dissemination of B-ALL. We identified CD9 as a potential regulator of B-ALL cell adhesion and a new factor involved in CXCR4-mediated migration and homing, through the promotion of actin rearrangement in response to CXCL12. We also characterized the effect of CD9 protein expression on RAC1 activation, which had an impact on blast migration and engraftment. Finally, we described, for the first time, the influence of CD9, mediated by RAC1 signaling, on B-cell chemotactic migration and homing in the testis. Our work provides evidence for an impact of CD9 on the ability of pre-B leukemic cells to disseminate to testes, through its effects on migration and homing, and suggests that CD9 may be a key player in late relapses of B-ALL, which are currently poorly understood.

Transcription has turned out to be a discontinuous process when imaged at a single cell level. This observation is referred to as transcriptional bursting or pulsing and has been detected in a variety of organisms ranging from bacteria to mammalian cells. The dynamics of transcriptional pulsing are influenced by the properties intrinsic to the transcriptional process, as well as by upstream factors: chromatin environment, signalling molecules, cell cycle stage etc. In the first part of this thesis, we focused on the regulation of transcriptional pulsing in the nucleolus. Using imaging of living cells, we detected pulsatile transcription of a transgene with nucleolar localization whose expression was mediated by RNA polymerase II. In the second part of the thesis, we investigated the relationship between chromatin decondensation and transcriptional dynamics. We used hyperosmotic medium to induce global condensation of chromatin and revealed that upon chromatin decondensation, a transient spike in transcriptional intensity occurs in induvial living cells. Next, we analysed expression of TFRC and POLR2A genes in several cell cycle stages using single molecule RNA FISH. We detected increase in both frequency and size of transcriptional pulses during a limited time window which coincided with chromatin...

Le virus des nervures jaunes et nécrotiques de la betterave (Beet necrotic yellow vein virus, BNYVV) est l’agent infectieux responsable de la rhizomanie de la betterave sucrière, une maladie caractérisée par une prolifération anarchique du chevelu racinaire. Le Beet soil-borne mosaic virus (BSBMV) appartient également au genre Benyvirus mais n’est retrouvé qu’en Amérique du Nord. Ce virus, identifié pour la première fois au Texas, est morphologiquement et génétiquement semblable au BNYVV mais sérologiquement éloigné. Compte tenu des différences moléculaires existant, le BSBMV et BNYVV correspondent à deux espèces virales distinctes. Mon projet de thèse a consisté à étudier les interactions moléculaires entre le BNYVV et le BSBMV et rechercher les mécanismes impliqués dans la pathogénicité de ces deux virus. Des clones complets cDNA infectieux du BNYVV étaient disponibles, tout comme ceux de BSBMV. Compte tenu de l’aspect versatile de l’obtention de transcrits infectieux de ces différents clones, j’ai entrepris de produire des clones cDNA de chacun des ARN viraux sous contrôle d’un promoteur constitutive végétal pour initier l’infection par agroinfiltration. Les plantes hôtes Chenopodium quinoa et Nicotiana benthamiana ont été inoculées par des transcrits et agroinfiltrées pour initier l’infection virale et étudier l’interaction entre les ARN génomiques 1 et 2 des deux virus et étudier les propriétés de constructions chimères. En parallèle à ce travail, j’ai réalisé la caractérisation du suppresseur de RNA silencing du BSBMV en le comparant à celui du BNYVV. / The genus Benyvirus includes the most important and widespread sugar beet viruses transmitted through the soil by the plasmodiophorid Polymyxa betae. In particular Beet necrotic yellow vein virus (BNYVV), the leading infectious agent that affects sugar beet, causes an abnormal rootlet proliferation known as rhizomania. Beet soil-borne mosaic virus (BSBMV) is widely distributed in the United States and, up to date has not been reported in others countries. My PhD project aims to investigate molecular interactions between BNYVV and BSBMV and the mechanisms involved in the pathogenesis of these viruses.BNYVV full-length infectious cDNA clones were available as well as full-length cDNA clones of BSBMV RNA-1, -2, -3 and -4. Handling of these cDNA clones in order to produce in vitro infectious transcripts need sensitive and expensive steps, so Ideveloped agroclones of BNYVV and BSBMV RNAs, as well as viral replicons allowing the expression of different proteins.Chenopodium quinoa and Nicotiana benthamiana plants have been infected with in vitro transcripts and agroclones to investigate the interaction between BNYVV and BSBMV RNA-1 and -2 and the behavior of artificial viral chimeras. Simultaneously I characterized BSBMV p14 and demonstrated that it is a suppressor of posttranscriptional gene silencing sharing common features with BNYVV p14.

Orientador: Michel Georges Albert Vincentz / Dissertação (mestrado) - Universidade Estadual de Campinas, Instituto de Biologia / Made available in DSpace on 2018-08-09T01:42:08Z (GMT). No. of bitstreams: 1 Silveira_AmandaBortolini_M.pdf: 20873886 bytes, checksum: 0c34c8a141f7bb11f8f3176ba7a976e0 (MD5) Previous issue date: 2007 / Resumo: O crescimento e o desenvolvimento dos organismos são baseados na capacidade celular de expressão gênica diferencial que resulta, principalmente, do controle da taxa de iniciação da transcrição por fatores reguladores de transcrição (FTs). FTs do tipo Basic Leucine QQjJer(bZIP) fQram descritos em todos os eucariotos. Seu domínio conservado é constituído de uma região de ligação ao DNA rica em aminoácidos básicos, flanqueada a um zíper de leucinas responsável pela dimerização. Em angiospermas, os bZIPs são reguladores importantes de processos específicos como fotomorfogênese, desenvolvimento de órgãos, elongação celular, controle do balanço de carbono/nitrogênio, mecanismos de defesa, via de sinalização de hormônios e sacarose, controle osmótico e florescimento. Mostramos que os genomas de Arabidopsis thaliana e Orysa sativa codificam para um conjunto completo e não redundante de 76 e 113 fatores bZIP respectivamente, que foram organizados em 11 grupos de proteínas evolutivamente relacionadas e 33 Possíveis Grupos de Genes Ortólogos (PoGO) de mono e eudicotiledôneas, o que deve permitir racionalizar o processo de caracterização funcional destes fatores em angiospermas. O Grupo C, que inclui genes homólogos ao lócus de regulação Opaco-2 (02) de milho, está organizado em três PoGOS, que possivelmente desempenham três funções ancestrais de angiospermas. Em Arabidopsis estas três possíveis funções ancestrais estão representadas por quatro genes (bZIP' 02 !1omologous, Bzo2h), Bzo2h3/AtbZIP63 (PoGO C1), Bzo2h1/AtbZIP10 e Bzo2h4/ AtbZIP25 (PoGO C2) e Bzo2h2/AtbZIP9 (PoGO C3). Visando um melhor conhecimento sobre a evolução das funções dos fatores bZIP de angiospermas do Grupo C, iniciamos a caracterização funcional de~tes quatro reguladores, focando principalmente em AtbZIP9, um gene único representativo de uma função ancestral de angiospermas e cujo papel ainda é desconhecido. Notamos que a expressão de AtbZIP9 é restrita as células do floema e regulada por glicose, ácido abscísico e citocinina, sugerindo que este gene integra as vias de sinalização destes sinais metabólicos e hormonais no floema. Abordagens de genética reversa como RNAi, knockout e superexpressão não permitiram elucidar de maneira clara a atuação de AtbZIP9 no ciclo de vida de Arabidopsis, indicando que mecanismos de regulação pós-transcricional e/ou redundância genética atuam sobre este gene. Visando dar continuidade e ampliar o estudo funcional de AtbZIP9, foram obtidas linhagens transgênicas de Arabidopsis expressando versões modificadas deste gene que codificam para proteínas ativadoras constitutivas fortes da transcrição. Estas novas versões de AtbZIP9 são teoricamente capazes de ativar de maneira constitutiva a expressão dos genes alvos de AtbZIP9, contornando assim, as dificuldades decorrentes da análise de famílias gênicas que apresentam redundância funcional. Quando comparados a plantas selvagens, transformantes primários para ativadores constitutivos fortes apresentaram diversas alterações de morfologia foliar, além de mudanças metabólicas e fisiológicas como acúmulo de compostos fenólicos em folhas, sintomas de morte celular e senescência. A análise destes transformantes ainda sugere uma possível participação de AtbZIP9 no controle do desenvolvimento do sistema vascular de raízes e folhas. Suspeitamos que as alterações de morfologia foliar e fisiologia observadas possivelmente representem conseqüências de mudanças nas propriedades funcionais de transporte do floema, decorrentes de defeitos no processo de diferenciação e organização das células do cilindro vascular / Abstract: Transcriptional regulatory factors (TFs) play an important role in controlling growth and development of ali organisms. bZIPs TFs have been described in ali eukaryotes and are characterized by a basic aminoacid rich DNA binding domain and a leucine zipper, responsible for dimerization. bZIPs have been reported to act in several different plantspecific processes such as organ development, cell elongation, defense mechanism, hormones and sucrose signalization, light response, control of nitrogen/carbon balance, osmotic control and flowering. We showed that Arabidopsis thaliana and Orysa sativa genomes encode a complete and non-redundant set of 76 and 113 bZIP transcription factors, respectively, which were divided into 11 unique groups of homologous genes. More detailed phylogenetic analysis led to the identification of 33 Possible Groups of Monocot and Eudicot Orthologous Genes (PoGO), which allows rationalizing functional studies in angiosperms. Group C, which includes genes homologous to the maize Opaque-2 locus, is formed by three PoGOs, suggesting that this group represents three ancestral functions among angiosperms. In Arabidopsis these three possible ancestral functions may be represented by the bZIP Qpaque-2. homologous genes (Bzo2h), Bzo2h3/AtbZIP63 (PoGO C1), Bzo2h1/AtbZIP10 and Bzo2h4/AtbZIP25 (PoGO C2) and Bzo2h2/AtbZIP9 (PoGO C3). To get insight into the evolution pattern and function of Group C members, we have iniciated the functional characterization of the Bzo2h genes concentrating initially on AtbZIP9, a unique gene that represents an ancestral function and for which no functional informational is available. We showed that AtbZIP9 expression is restricted to phloem cells and regulated by glucose, abscisic acid and cytokinin, suggesting that this gene is an element of the signalization pathways of these metabolic and hormonal signals in the phloem. Reverse genetic approaches such as RNAi, knockout and superexpression failed to reveal the biological function of AtbZIP9 in Arabidopsis life cycle and suggested that post-transcriptional regulation and/or functional redundancy may act on AtbZIP9. In order to improve our Rnowledge on AtbZIP9 function, Arabidopsis transgenic lines expressing constitutive transcriptional activator versions of AtbZIP9 were obtained. Since such modified versions of AtbZIP9 are theoretically able to promote the superexpression of AtbZIP9 target genes, this strategy should be independent of functional redundancy. When compared to wild type plants, primary transformants for constitutive transcriptional activator versions of AtbZIP9 showed alterations of leaf morphology, as well as metabolic and physiologic modifications, such as phenolic compound accumulation in leaves, cell death and senescence symptoms. Analyses of this transformants also suggest that AtbZIP9 is possibly involved in the control of leaf and root vascular system development. We suspect that the alteration of leaf morphology and physiology observed in primary transformants possibly reflects consequences of changes in phloem transport functional properties, due to defects in vascular cylinder cell differentiation and organization / Mestrado / Genetica Vegetal e Melhoramento / Mestre em Genética e Biologia Molecular

O iodo em excesso promove o efeito Wolff-Chaikoff. Oligominerais já foram descritos como potenciais reguladores da expressão de proteínas. Tornou-se interessante avaliar se o iodo interferiria com a expressão do mRNA da NIS, em curtos períodos de tempo. Foram realizados, em ratos e células (de 30 min24h), estudos de expressão, comprimento de cauda poli-A e recrutamento para polissomos, do mRNA de NIS. Observou-se, in vivo e in vitro, que o excesso de iodo promoveu diminuição da expressão e do comprimento da cauda poli-A do mRNA de NIS, em todos os períodos estudados, além de promover menor recrutamento deste mRNA para os polissomos. A diminuição da cauda poli-A do mRNA de NIS pode ter aumentado sua instabilidade/degradação e também ter sido responsável por uma menor eficiência de tradução deste transcrito. Conclui-se que: (a) o iodo regula pós-transcricionalmente a expressão gênica da NIS, sendo fundamental nos processos que norteiam o efeito Wolff-Chaikoff e (b) oligoelementos têm relevância na regulação da expressão de proteínas relacionadas ao seu transporte. / Iodide in excess exerts the Wolff-Chaikoff effect. It is described that some minerals can regulate the expression of proteins. This study aimed to investigate if the iodide could modify the expression of NIS mRNA, in short periods of time. Rats and cells, divided in time-groups of 30 min up to 24h, were used in studies of expression, poly-A tale length and polysomal profile of NIS mRNA. Both in vivo and in vitro studies showed that the iodide treatment promoted a reduction in the expression and the poly-A length of NIS mRNA, in all time-groups, and decreased its recruitment to the polysomes. It is possible that the reduction of NIS mRNA poly-A tale length has increased the instability/degradation of this transcript, and impaired the translation efficiency of it. Concluding: a) the iodine exerts a post-transcriptional regulation of NIS mRNA expression, being essencial in the processes that guide the Wollf-Chaikoff effect; b) the oligoelements have an extremely important role in the expression regulation of proteins related to their transport.

INTRODUÇÃO: O meduloblastoma, tumor maligno do Sistema Nervoso Central mais comum em crianças, foi inicialmente descrito de forma uniforme em 1925 por Bailey e Harvey Cushing. A despeito do avanço diagnóstico e terapêutico, os índices de morbimortalidade persistem altos. Grupos epidemiologicamente semelhantes podem ter desfechos diferentes, e evoluções desfavoráveis ocorrem em pacientes com marcadores de bom prognóstico. Os avanços nas pesquisas em biologia molecular procuram explicar os diferentes comportamentos da doença, e de forma sistemática, buscam identificar genes que sirvam como alvos terapêuticos, já que o tratamento disponível atualmente ainda é bastante insatisfatório e com muitos efeitos colaterais. Simeone e colaboradores identificaram os genes OTX1 e OTX2, presentes em humanos, e cuja função é organizar, compartimentalizar e hierarquizar a formação do sistema nervoso central, especialmente o cerebelo. Os genes OTX1 e OTX2 são expressos no tecido cerebelar em humanos até a nona semana de vida extra-uterina, exclusivamente. Os mesmos autores também identificaram que os mesmos genes são alvo terapêutico do ácido transretinóico, que inibe a expressão gênica. Estudos prévios demonstraram a expressão dos genes OTX1 e OTX2 em meduloblastomas, o que torna o ácido uma potencial terapêutica para estes tumores, assim como os genes OTX1 e OTX2 potenciais alvos para desenvolvimento de novas drogas terapêuticas. OBJETIVOS: Estudar a prevalência dos genes OTX1 e OTX2 em uma amostra de 60 pacientes, e estabelecer correlações entre a expressão gênica e aspectos clínicos, patológicos e de evolução. CASUÍSTICA E MÉTODO: Realizada análise retrospectiva de 60 pacientes com diagnóstico meduloblastoma, operados no Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, e no Hospital do Câncer de Barretos. Organizado um banco de dados de 60 pacientes contendo dados da expressão gênica dos genes OTX1 e OTX2 (obtida através da técnica de PCR em tempo real) e dados clínico-epidemiológicos. Realizados testes estatísticos para se estabelecer correlação entre dados clínico-patológicos e de expressão gênica. RESULTADOS: O gene OTX1 foi expresso em 52% da população estudada, e tal expressão variou com a idade (sendo maior em adultos), localização (preferência por hemisfério) e tipo histológico (desmoplásico). O gene OTX2 foi expresso em 62% da população estudada, e tal expressão variou com a idade (sendo maior quanto menor a faixa etária), localização (preferência por vérmis) e tipo histológico (clássico). Houve correlação estatística entre a expressão do gene OTX2 e o desenvolvimento de metástases leptomeníngeas. CONCLUSÕES: Na população estudada, a expressão dos genes OTX1 e OTX2 corrobora a impressão de seu papel importante na patogênese dos meduloblastomas, e é dependente da idade do paciente, da localização tumoral e do tipo histológico. Dada a sensibilidade do gene ao ácido transretinóico, a identificação deste perfil populacional pode significar no futuro novas perspectivas de tratamento. / INTRODUCTION: Medulloblastoma, the most common malignant tumor of the central nervous system in children, was first uniformly described in 1925 by Bailey and Harvey Cushing. Despite the diagnostic and therapeutic advances, the morbidity and mortality rates remain high. Epidemiologically similar groups may have different outcomes, and adverse developments occur in patients with markers of good prognosis. Advances in molecular biology research seeks to explain the different behaviors of the disease, and consistently seek to identify genes that serve as drug targets, since the treatment currently available is still unsatisfactory and with many side effects. Simeone and colleagues identified genes OTX1 and OTX2 in humans, and whose function is to organize, prioritize and compartmentalize the formation of the central nervous system, especially the cerebellum. OTX1 and OTX2 genes are expressed in cerebellar tissue in humans until the ninth week of extra uterine life, exclusively. The same authors also found that the same genes are therapeutic target of trans-retinoic acid, which inhibits gene expression. Previous studies have demonstrated the expression of OTX1 and OTX2 genes in medulloblastomas, which makes the acid a potential therapy for these tumors, as well as the genes OTX2 and OTX1 potential targets for developing new therapeutic drugs. OBJECTIVES: To study the prevalence of OTX1 and OTX2 genes in a sample of 60 patients, and to establish correlations between gene expression and clinical, pathological and follow up aspects. CASUISTICS AND METHODS: A retrospective analysis of 60 patients diagnosed with medulloblastoma, assisted at Hospital of the Faculty of Medicine, University of São Paulo, and the Cancer Hospital of Barretos. Organized a database of 60 patients which contains the gene expression of OTX1 and OTX2 genes (obtained through the technique of real-time PCR) and clinical and epidemiological data. Performed statistical tests to establish a correlation between clinical-pathological and gene expression. RESULTS: The OTX1 gene was expressed in 52% of the population studied, and such expression varied with age (being higher in adults), location (preferably by hemisphere) and histology (desmoplastic). The OTX2 gene was expressed in 62% of the studied population, and such expression varied with age (being higher the younger the age group), location (preferably vermis) and histological type (classical). A statistical correlation between the expression of OTX2 gene and development of leptomeningeal metastases was observed. CONCLUSIONS: In the studied population, the expression of OTX1 and OTX2 genes corroborates the impression of his role in the pathogenesis of medulloblastomas, and is dependent on patient age, tumor location and histological type. Given the sensitivity of the gene-trans retinoic acid, the identification of the population profile in the future will represent new opportunities for treatment.